Article Information
History
- June 29, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Olga Martínez-Sáez1,2,3,
- Tomás Pascual1,2,3,4,
- Fara Brasó-Maristany1,2,3,
- Nuria Chic1,2,3,
- Blanca González-Farré1,3,5,
- Esther Sanfeliu1,3,5,
- Adela Rodríguez2,
- Débora Martínez1,2,3,
- Patricia Galván1,2,3,
- Anna Belén Rodríguez1,2,3,
- Francesco Schettini1,3,6,
- Benedetta Conte1,3,7,
- Maria Vidal1,2,3,
- Barbara Adamo1,2,3,
- Antoni Martinez5,
- Montserrat Muñoz1,2,3,
- Reinaldo Moreno1,2,3,
- Patricia Villagrasa1,
- Fernando Salvador1,
- Eva M. Ciruelos1,8,
- Iris Faull9,
- Justin I. Odegaard9 and
- Aleix Prat1,2,3,#
- 1SOLTI Breast Cancer Research Group, Barcelona, Spain
- 2Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain
- 3Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
- 4Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- 5Department of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain
- 6Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
- 7Department of Medical Oncology U·O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132, Genova, Italy
- 8Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain
- 9Guardant Health, Inc., Redwood City, California
- ↵#Corresponding author
Aleix Prat, MD, PhD, Hospital Clinic of Barcelona, Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Villarroel 170, 08035, Barcelona, Spain, Email: alprat{at}clinic.cat, Telephone number: (+34) 93 227 54 00